Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $754.38 | 9 | 74.9% |
| Food and Beverage | $252.44 | 3 | 25.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $257.53 | 3 | $0 (2018) |
| Incyte Corporation | $184.00 | 2 | $0 (2020) |
| Astellas Pharma US Inc | $169.99 | 2 | $0 (2018) |
| Lilly USA, LLC | $167.86 | 2 | $0 (2018) |
| Millennium Pharmaceuticals, Inc. | $117.04 | 1 | $0 (2017) |
| Amgen Inc. | $99.00 | 1 | $0 (2018) |
| PFIZER INC. | $11.40 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $99.00 | 1 | Incyte Corporation ($99.00) |
| 2018 | $691.78 | 9 | Astellas Pharma US Inc ($169.99) |
| 2017 | $216.04 | 2 | Millennium Pharmaceuticals, Inc. ($117.04) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/07/2020 | Incyte Corporation | — | Education | Cash or cash equivalent | $99.00 | General |
| 11/30/2018 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $84.58 | General |
| Category: Oncology | ||||||
| 11/20/2018 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $97.12 | General |
| 08/30/2018 | Astellas Pharma US Inc | — | Education | In-kind items and services | $74.99 | General |
| 08/23/2018 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $70.74 | General |
| 07/11/2018 | Incyte Corporation | — | Education | Cash or cash equivalent | $85.00 | General |
| 06/06/2018 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Education | In-kind items and services | $73.95 | General |
| Category: Oncology | ||||||
| 05/08/2018 | Astellas Pharma US Inc | — | Education | In-kind items and services | $95.00 | General |
| 05/03/2018 | Amgen Inc. | — | Education | In-kind items and services | $99.00 | General |
| 04/18/2018 | PFIZER INC. | SUTENT (Drug) | Education | In-kind items and services | $11.40 | General |
| Category: ONCOLOGY;RESPIRATORY | ||||||
| 10/30/2017 | Millennium Pharmaceuticals, Inc. | VELCADE (Drug) | Education | In-kind items and services | $117.04 | General |
| Category: Oncology | ||||||
| 09/21/2017 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 14 | 15 | $4,112 | $1,194 |
| 2021 | 5 | 68 | 158 | $67,986 | $16,176 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 14 | 15 | $4,112 | $1,194 | 29.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 15 | 40 | $19,320 | $4,561 | 23.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 11 | 50 | $16,700 | $4,174 | 25.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 14 | 18 | $11,754 | $2,912 | 24.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 14 | 36 | $11,700 | $2,781 | 23.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 14 | 14 | $8,512 | $1,748 | 20.5% |
About Dr. Daniel Guy, MD
Dr. Daniel Guy, MD is a Internal Medicine healthcare provider based in Eugene, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2014. The National Provider Identifier (NPI) number assigned to this provider is 1366860553.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Guy, MD has received a total of $1,007 in payments from pharmaceutical and medical device companies, with $99.00 received in 2020. These payments were reported across 12 transactions from 7 companies. The most common payment nature is "Education" ($754.38).
As a Medicare-enrolled provider, Guy has provided services to 82 Medicare beneficiaries, totaling 173 services with total Medicare billing of $17,371. Data is available for 2 years (2021–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location Eugene, OR
- Active Since 04/03/2014
- Last Updated 06/02/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1366860553
Products in Payments
- IMBRUVICA (Drug) $172.95
- VELCADE (Drug) $117.04
- DARZALEX (Biological) $84.58
- SUTENT (Drug) $11.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Eugene
Luke Fletcher, Md, MD
Internal Medicine — Payments: $29,592
Miho Dougherty, M.d, M.D
Internal Medicine — Payments: $11,294
Karthik Mahadevan, Md, MD
Internal Medicine — Payments: $6,925
Kirk Jacobson, M.d, M.D
Internal Medicine — Payments: $5,643
Dr. Shehzad Jinnah, Md, MD
Internal Medicine — Payments: $3,561
Dr. Jane Mossberg, M.d, M.D
Internal Medicine — Payments: $2,402